Websites Hosted in ns1.bms.com Nameserver
The Nameserver ns1.bms.com have a IP Address of 198.155.167.250 which is hosted on United States of America.
Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Bristol-Myers Squibb - A global biopharmaceutical company
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Bristol-Myers Squibb: ZymoGenetics
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Bristol-Myers Squibb - Global Biopharmaceutical Company
Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
ORENCIA® (abatacept) | Official Patient Site
Take an assessment; learn about ORENCIA On Call; get help with insurance questions, co-pay assistance, financial support; watch the ORENCIA TV commercial; review the Important Safety Information and Full Prescribing Information
Investigational Nivolumab Treatment in Cancer
Overview of an investigational nivolumab treatment being studied for several types of cancer, including lung cancer, renal cell carcinoma, and melanoma.
Bristol-Myers Squibb (BMS) - entreprise biopharmaceutique d’envergure
Découvrez Bristol-Myers Squibb et sa mission visant à découvrir, développer et fournir des médicaments innovants qui aident les patients à vaincre des maladies graves.
ORENCIA® (abatacept) | Official Patient Site
ORENCIA® (abatacept) is a prescription medication for moderate to severe Adult Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Adult Psoriatic Arthritis. Please see Indication and Important Safety Information.
Bristol-Myers Squibb - Global Biopharmaceutical Company
Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
NULOJIX® (belatacept)-Official Site For US Healthcare Professionals
NULOJIX® (belatacept) official HCP Web site; View Important Safety Information, including Boxed WARNINGS and Full Prescribing Information.
EG_DTC_AR_WWREG_LoginPage
Immune-related adverse reactions (irARs) that have been reported in association with nivolumab use both in monotherapy and in combination therapy with ipilimumab
EG_HCP_EN_WWREG_LoginPage
Immune-related adverse reactions (irARs) that have been reported in association with nivolumab use both in monotherapy and in combination therapy with ipilimumab
DNS resolution error | apixabannewsletter.com | Cloudflare
Renal Cell Carcinoma | OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Co
OPDIVO + YERVOY combination for certain people with kidney cancer that has spread. See Boxed WARNING for YERVOY, Important Safety Information and Indication.